DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202309

A prospective clinical study of foetomaternal outcome in relation to oligohydramnios in pregnancies beyond 36 weeks of gestation

B. S. Meena, Nimisha Gupta, Oby Nagar, Swati Trivedi

Abstract


Background: Amniotic fluid is contributed by both mother and foetus. It plays a vital role in foetal growth. The main purpose of this study was to evaluate the foetomaternal outcome in pregnant females with oligohydramnios beyond 36 weeks of gestation.

Methods: This study was conducted on 230 pregnant females beyond 36 weeks of gestation with decreased liquor clinically and confirmed sonographically. It was conducted from May 2018 to May 2019. Females with leaking per vaginum, patients who did not give consent and with intrauterine foetal death were excluded. Complete labour record was made. Assessment of maternal outcome was done in terms of mode of delivery and foetal outcome was done in terms of birth weight, Apgar score at one and five-minute, respiratory distress, meconium aspiration, seizures in first 24 hours of life, congenital malformations, neonatal intensive care unit admission and death of baby.

Results: A total of 230 pregnant females met the inclusion criteria who were having AFI <5. 121 (53%) females were primigravida and 119 (52%) underwent for caesarean section. Most common indication of LSCS was foetal distress. Apgar score at 1 minute was <7 in 97 (42%) babies and after 5 minutes, it was <7 in 93 (40%) babies. Other neonatal outcome results were IUGR in 59 (26%) babies, meconium aspiration syndrome in 52 (23%) babies, respiratory distress in 92 (40%) babies, congenital malformation in 6 (3%) babies, NICU admission of 93 (40%) babies and neonatal death of 11 (5%) babies.

Conclusions: Oligohydramnios increases the chances of maternal morbidity and perinatal morbidity and mortality.


Keywords


Amniotic fluid index, Apgar score, Oligohydramnios, Single vertical pocket

Full Text:

PDF

References


Queeran JT, Gadow EC. Polyhydramnios: chronic versus acute. Am J Obstet Gynecol. 1970;108:349-52.

Magann EF, Doherty DA, Chauhan SP, Busch FW, Mecacci F, Morrison JC. How well do the amniotic fluid index and single deepest pocket indices (below the 3rd and 5th and above the 95th and 97th percentile) predict oligohydramnios and hydramnios? Am J Obstet Gynecol. 2004;190:164-9.

Sowmya K, Varghese B, Borkar YB. Effect of isolated oligohydramnios in otherwise normal term pregnancy. Int J Biomed Res. 2014;5(2):98-101.

Chamberlain PF, Manning FA, Morrison I, Harman CR, Lange IR. Ultrasound evaluation of amniotic fluid volume. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome. Am J Obstet Gynecol. 1984;150(3):245-9.

Phelan JP, Ahn MO, Smith CU, Rutherford SE. Amniotic fluid index in normal human pregnancy. J Reprod Med. 1987;32:601-4.

Moore TR. Clinical assessment of amniotic fluid. Clin Obstet Gynaecol. 1997;40(2):303-13.

Yoshimura S, Masuzaki H, Gotoh H, Ishimara T. Fetal redistribution of blood flow and amniotic fluid volume in growth retarded foetuses. Early Hum Dev. 1997;47:297.

Voxman EG, Tran S, Wing DA. Low amniotic fluid index as a predictor of adverse fetal outcome. J Perinatol. 2000:22(4):282-5.

Casey BM, McIntire DD, Bloom SL, Lucas MJ, Santos R. Pregnancy outcome after antepartum diagnosis of oligohydramnios at or beyond 34weeks gestation. Am J Obstet Gynecol. 2001:82(4);909-12.

Ghimire S, Ghimire A, Chapagain S, Paudel S. Pregnancy cases in patients with oligohydramnios after 28 weeks of gestation. Int J Adv Med Health Res. 2016;3:68-72.

Garmel SH, Chelmow D, Sha SJ, Roan JT, D'Alton ME. Oligohydramnios and the appropriately grown fetus. Am J Perinatol. 1997;14(6):359-63.

Jandial C, Gupta S, Sharma S, Gupta M. Perinatal outcome after antepartum diagnosis of oligohydramnios at or beyond 34 weeks of gestation. JK Sci. 2007;9(4):213-4.

Guin G, Punekar S, Lele A, Khare S. A prospective clinical study of feto-maternal outcome in pregnancies with abnormal liquor volume. J Obstet and Gynaecol India. 2011;61(6):652-5.

Ahmar R, Sadia P, Kumari S, Kumar M. Neonatal and maternal outcome in oligohydramnios: a prospective study. Int J Contemp Pediatr. 2018;5(4):1409-13.

Kaur T, Sood R. Feto-maternal outcome in pregnancies with abnormal AFI. J Dental Med Sci. 2016;15(4):31-5.

Manning FA, Hill LM, Platt LD. Qualitative amniotic fluid volume determination by ultrasound: Antepartum detection of intrauterine growth retardation. Am J Obstet Gynecol. 1981;139(3):254- 8.

Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF. A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis. Am J Obstet Gynecol. 2007;197(2):207.e1-7.

Zhang J, Troendle J, Meikle S, Klebanoff MA, Rayburn WF. Isolated oligohydramnios is not associated with adverse perinatal outcome. BJOG. 2004;111(3):220-5.

Wolff F, Schaefer R. Oligohydramnios-perinatal complications and diseases in mother and child. Geburtshilfe Frauenheilkd. 1994;54(3):139-43.